Relief Therapeutics Holding SA (OTCMKTS:RLFTF – Get Free Report) traded down 9.1% during mid-day trading on Wednesday . The stock traded as low as $3.21 and last traded at $3.36. 18,962 shares changed hands during trading, an increase of 466% from the average session volume of 3,349 shares. The stock had previously closed at $3.70.
Relief Therapeutics Trading Down 9.1%
The company has a 50 day simple moving average of $3.58 and a 200-day simple moving average of $3.10.
Relief Therapeutics Company Profile
Relief Therapeutics Holding AG, a biopharmaceutical company, focuses on identification, development, and commercialization of novel, patent protected products for the treatment of metabolic, dermatological, and pulmonary rare diseases in Switzerland, Europe, North America, and internationally. The company offers SETOFILM/ONDISSOLVE for radiotherapy induced nausea and vomiting, and chemotherapy induced nausea and vomiting, as well as postoperative induced nausea and vomiting.
Read More
- Five stocks we like better than Relief Therapeutics
- How to Invest in the Best Canadian Stocks
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Relief Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Relief Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
